BioMedica Ribraxx 30 or 90 Sachets
BioMedica Ribraxx 30 or 90 Sachets
Couldn't load pickup availability
How to Purchase Practitioner-Only Products
To purchase practitioner-only products, a consultation with our qualified health practitioner Raewyn Richarson is required.
If you place an order without having had a consultation, we will get in touch to discuss your health needs before your order can be dispatched.
This process ensures we recommend the most appropriate and effective products for your individual wellbeing.
Ribraxx
Ribraxx is a unique arabinoxylan compound derived from rice bran. Its water soluble hemicellulose-β fraction is partially hydrolysed by enzymes extracted from a cultured medium of Shiitake mushroom (Lentinula edodes). Ribraxx is of low molecular weight and is easily absorbed.
Highlights
- Highly credible arabinoxylan compound with over 70/27 human clinical) published studies; sold in 52 countries for over 14 years.
- Consists of arabinoxlyan compound extracted from rice bran that has been enzymatically broke down by shiitake mushroom extract.
- Rich in polysaccharides and proteoglycans.
- Neutral tasting power and convenient individual sachets
Dosing of RBAC
500mg daily or 1g three times per week
- Long term use
- Prophylactic
- Non-serious condition
- Slow disease progression
6g daily in divided doses
- Palliative care
- Advance staging
- Poor prognosis
- Rapid disease progression
Major therapeutic properties of RBAC
Immunomodulatory action
- Upgrade NK cell activity
- Enhance phagocytic cell functions (macrophages, neutrophilis, monocytes)
- Induce DC maturation and activation
- Increase proliferation of T and B Cells
Angiogenesis action
- Suppress VEGF-induced proliferation
- Inhibit activation of VEGF receptor 2
- Reduce the productuon of Akt, ERK1/2 and p38 MAPK
Antioxidant action
- Possess high scavenging activity against O2 and OH
- Normalise LPx, GSH, and MDA levels
- Enhance the activity of SOD, GPx, CAT, and GST
- Increase expression of Nrf2 and ATRE
Anti-inflammatory action
- Compete binding to immune-stimulating ligands, such as TRL4
- Modulate the signally cytokines, including TNF-a, INFy, IL_1βIL-10 and more
- Reduce systemic inflammatory markers e.g. CRP, ESR, RA
Share
